With the continuous expansion of the traditional Chinese medicine formula granule market, improving the mechanization capability will be crucial

Since October 2021, the State Food and Drug Administration has published the "Letter on the Reply to Proposal No.
4117 of the Fourth Session of the 13th National Committee of the Chinese People's Political Consultative Conference", disclosing that relevant departments have decided to appropriately include traditional Chinese medicine formula granules in the scope of national medical insurance reimbursement.
, the coverage of traditional Chinese medicine formula granules in the country's medical insurance began to expand
.
The market of traditional Chinese medicine formula granules is continuing to expand (photo source: Pharmaceutical Network) The market of traditional Chinese medicine formula granules will continue to expand At present, Beijing, Zhejiang, Hebei, Hunan and other provinces have begun to include traditional Chinese medicine formula granules in the scope of medical insurance payment
.
For example, on October 27, 2021, the Sichuan Provincial Food and Drug Administration issued a notice on printing and distributing the "Implementation Rules for the Administration of Traditional Chinese Medicine Formula Granules in Sichuan Province".
Explain and stipulate that the notice will be implemented from November 1
.
Among them, it is worth noting that not long ago, the website of the Fujian Provincial Medical Insurance Bureau released the "Notice of the Fujian Provincial Medical Insurance Bureau on Doing a Good Job in the Medical Insurance Management of Traditional Chinese Medicine Formula Granules" (hereinafter referred to as the "Notice")
.
The "Notice" shows that after being reviewed by experts, qualified Chinese medicine formula granules will be included in the payment scope of the basic medical insurance fund of Fujian Province according to 70% of the sales price, and the limited payment scope of the corresponding Chinese medicine decoction pieces will be implemented with reference to the provisions
.
On the whole, Fujian's policy basically covers all the varieties of traditional Chinese medicine formula granules currently sold in public hospitals in the province, which means that the category of formula granules is included in the scope of medical insurance
.
The industry believes that with the expansion of hospitals and medical insurance coverage, the market of traditional Chinese medicine formula granules is expected to continue to grow
.
By 2030, the market size may reach 100 billion yuan, attracting more traditional Chinese medicine companies to enter the field
.
However, it should be noted that since the field of traditional Chinese medicine formula granules relies on a high degree of mechanization and corresponding production experience, with the expansion of the market, higher quality standards will also be required in terms of products
.
Facing the 100 billion TCM formula granule market, pharmaceutical machine companies are facing challenges.
TCM formula granules are in the middle reaches of the TCM industry chain.
The upstream includes Chinese herbal medicine, raw materials, etc.
, as well as the equipment industry, that is, the research and processing equipment of TCM formula granules.

.
In recent years, with the refinement of the national standards for TCM formula granules by the State Pharmacopoeia Commission, in order to meet the standards, TCM granule enterprises have continued to increase their requirements for related equipment, and their mechanization capabilities have also been continuously improved.
Therefore, in the industry It is expected that with the continuous expansion of the traditional Chinese medicine formula granule market, the upstream equipment industry will also usher in more opportunities and challenges
.
In fact, since last year, the State Food and Drug Administration, the National Medical Insurance Administration and other four departments issued the "Announcement on Ending the Pilot Work of TCM Formula Granules" (referred to as the "Announcement"), ending the 20-year pilot work of TCM formula granules.
Jiangsu Province, Guizhou, Jiangsu, Shaanxi, Yunnan, Guangdong and other provinces have successively issued work procedures for formulating quality standards for traditional Chinese medicine formula granules and requirements for application materials, and are actively implementing the accelerated and standardized development of the traditional Chinese medicine formula granule industry
.
In this context, more and more traditional Chinese medicine companies have begun to abandon traditional and backward pharmaceutical processes and equipment, and then use professional intelligent, automated, and digital equipment to boost the higher-quality development of the industry
.
It is reported that affected by this, more and more pharmaceutical equipment companies are also accelerating the innovation and upgrading of equipment to help Chinese medicine formula granule companies improve their mechanization capabilities
.
For example, in the research of intelligent Chinese medicine extraction equipment, Canaan Technology has been relatively active
.
It is reported that it has already invested heavily to build 3 intelligent Chinese medicine extraction equipment production lines for customers that can provide customized products
.
The production line consists of four major parts: intelligent production control center, intelligent processing production line, and intelligent monitoring and analysis center.
It mainly produces and develops intelligent Chinese medicine extraction equipment.
It is estimated that the annual output of Chinese medicine extraction equipment is 90 sets (sets)
.
Conclusion In general, at the moment when policies continue to help the development of the industry, the overall inflection point of the traditional Chinese medicine formula granule industry has been revealed.
Under this background, in the future, there will be high-quality, advanced technology and pharmaceutical equipment companies that meet industry standards, norms, and market demands.
It is expected to further promote the continuous and accelerated development of the traditional Chinese medicine formula granule industry in the direction of high quality
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.